# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-25-036637
Filing Date
2025-09-30
Accepted
2025-09-30 07:24:16
Documents
44
Period of Report
2025-09-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ef20056246_8k.htm iXBRL | 8-K | 33804
2 | EXHIBIT 99.1 | ef20056246_ex99-1.htm | EX-99.1 | 25713
3 | EXHIBIT 99.2 | ef20056246_ex99-2.htm | EX-99.2 | 59195
7 |  | ef20056246_ex99-2slide31.jpg | GRAPHIC | 109974
8 |  | ef20056246_ex99-2slide32.jpg | GRAPHIC | 519895
9 |  | ef20056246_ex99-2slide33.jpg | GRAPHIC | 97740
10 |  | ef20056246_ex99-2slide34.jpg | GRAPHIC | 80277
11 |  | ef20056246_ex99-2slide35.jpg | GRAPHIC | 201336
12 |  | ef20056246_ex99-2slide36.jpg | GRAPHIC | 187359
13 |  | ef20056246_ex99-2slide37.jpg | GRAPHIC | 65347
14 |  | ef20056246_ex99-2slide38.jpg | GRAPHIC | 152732
15 |  | ef20056246_ex99-2slide39.jpg | GRAPHIC | 222977
16 |  | ef20056246_ex99-2slide40.jpg | GRAPHIC | 172386
17 |  | ef20056246_ex99-2slide41.jpg | GRAPHIC | 167628
18 |  | ef20056246_ex99-2slide42.jpg | GRAPHIC | 83750
19 |  | ef20056246_ex99-2slide43.jpg | GRAPHIC | 118504
20 |  | ef20056246_ex99-2slide44.jpg | GRAPHIC | 132528
21 |  | ef20056246_ex99-2slide45.jpg | GRAPHIC | 50848
22 |  | ef20056246_ex99-2slide46.jpg | GRAPHIC | 121478
23 |  | ef20056246_ex99-2slide47.jpg | GRAPHIC | 115871
24 |  | ef20056246_ex99-2slide48.jpg | GRAPHIC | 130805
25 |  | ef20056246_ex99-2slide49.jpg | GRAPHIC | 78979
26 |  | ef20056246_ex99-2slide50.jpg | GRAPHIC | 162056
27 |  | ef20056246_ex99-2slide51.jpg | GRAPHIC | 146816
28 |  | ef20056246_ex99-2slide52.jpg | GRAPHIC | 214523
29 |  | ef20056246_ex99-2slide53.jpg | GRAPHIC | 195459
30 |  | ef20056246_ex99-2slide54.jpg | GRAPHIC | 207667
31 |  | ef20056246_ex99-2slide55.jpg | GRAPHIC | 137200
32 |  | ef20056246_ex99-2slide56.jpg | GRAPHIC | 324732
33 |  | ef20056246_ex99-2slide57.jpg | GRAPHIC | 76648
34 |  | ef20056246_ex99-2slide58.jpg | GRAPHIC | 198216
35 |  | ef20056246_ex99-2slide59.jpg | GRAPHIC | 212939
36 |  | ef20056246_ex99-2slide60.jpg | GRAPHIC | 77772
| Complete submission text file | 0001140361-25-036637.txt |  | 6835558

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | ird-20250930.xsd | EX-101.SCH | 3859
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | ird-20250930_lab.xml | EX-101.LAB | 21966
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | ird-20250930_pre.xml | EX-101.PRE | 16041
46 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20056246_8k_htm.xml | XML | 4051

Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 248-681-9815
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 251358154
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)